![](https://investorshub.advfn.com/uicon/677007.png?cb=1537174437)
Friday, July 27, 2018 10:07:56 AM
I don't "love" CELZ. I sure do like its prospects though. In all seriousness, the run it had in June has nothing to do with the market giving it a fair shake. That was likely as much manipulation as we have now, just the other direction. MM's do not care what the price is. High or Low, they have the privilege to make money on the up or down. Don't you wish you could? Too bad options are available for CELZ...
Anyway, I don't think anyone questions your intellect UVA. The key right now is to hold that mind back with a stick and do your best to be reasonable. By that, I don't mean doing every possible calculation and speculation as to the why's it run this way or that way. You are correct to say that markets,PPS and investors at large don't like surprises and they LOVE information which lends to the valuation calcs which nets confidence in PPS levels. The simple truth with CELZ is that they don't have enough to legally share at every waking moment. It's just a fact. They have to be so incredibly careful not to get tripped up and then, God forbid, be so foolish as to get themselves the dreaded skulls n bones on OTC. If you are in fact pursuing higher ed (pun intended) then know that your worst enemy will be the academic approach to evaluating this "scientific" project we call "investing" in CELZ.
This entire investment thesis should not be on what is "fair" by the market and the manipulators in these formative days for CELZ. It should SOLELY be based on what you think the stock will be worth in Sept or Dec based on the information you have today. Anything else is a fools errand and 100% guaranteed to send you to an insane asylum.
Hope you can find some peace in this grey fog. HODL and stop trying to out-think what can't be thunk.
Cheers!
-- Narrow is the way and few are those who find it. --
Recent CELZ News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 08:10:25 PM
- Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program • GlobeNewswire Inc. • 07/24/2024 01:00:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • GlobeNewswire Inc. • 07/10/2024 12:30:00 PM
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM